Daniel Karin Selected Research

Daniel Karin Research Topics

6	Neoplasms (Cancer) 10/2023 - 01/2019
3	Melanoma (Melanoma, Malignant) 02/2024 - 10/2022
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 09/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2020 - 01/2019
2	Fibrosis (Cirrhosis) 01/2020 - 01/2019
2	Cicatrix (Scar) 01/2019 - 09/2016
1	Infections 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Bites and Stings (Sting) 01/2023
1	Liver Diseases (Liver Disease) 01/2020
1	Carcinogenesis 01/2019

3	CytokinesIBA 01/2020 - 01/2019
2	Interferon-gamma (Interferon, gamma)IBA 02/2024 - 10/2023
2	Immune Checkpoint InhibitorsIBA 10/2022 - 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023
1	InterferonsIBA 01/2023
1	Phosphotransferases (Kinase)IBA 10/2022
1	LigandsIBA 10/2022
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2021
1	CREB-Binding ProteinIBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	I-antigenIBA 01/2021
1	TransferasesIBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	CholesterolIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	EnzymesIBA 01/2019
1	CarcinogensIBA 01/2019
1	NADP (NADPH)IBA 01/2019
1	NADPH Oxidase 1IBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	2-acetylphenothiazineIBA 01/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2019
1	fibulin 2IBA 04/2017
1	MesothelinIBA 04/2017
1	CA-125 Antigen (CA 125 Antigen)IBA 04/2017
1	Collagen Type I (Type I Collagen)IBA 09/2016

5	Therapeutics 01/2023 - 04/2017
1	Drug Therapy (Chemotherapy) 01/2021
1	Injections 01/2019
1	Intraperitoneal Injections 01/2019
1	Ligation 04/2017